K-12 Health Education, Health Communication, and Health Literacy: Strategies to Improve Lifelong Health.

To promote a health literate K-12 population, this chapter focuses on intersections of Health Literacy (HL), Health Education (HE) and Health Communication (HC) and urges collaborations among professionals from these disciplines as well as with stakeholders who share their interests and concerns. Core definitions and evolutionary highlights of these disciplines are presented, as well as their intersection and promise of impact on student academic and health outcomes. The Whole School, Whole Community, Whole Child (WSCC) model is used as an example of a framework embraced by education and health experts to help students become health literate. Internal and external stakeholders, models of what works, resources and strategies for developing or strengthening school health and health communication practice are presented. Selected contemporary threats to the social and emotional health and safety of youth are reviewed; as are successful, evidence-based, collaborative HE, HC, and HL programs and strategies. Finally, recommendations for future research and strategic actions in combining HE and HC for HL are discussed to empower, build resilience, and improve the lifelong health of children and adolescents as they become adults.

Raising Public Awareness of Clinical Trials: Development of Messages for a National Health Communication Campaign.

Clinical trials are essential for developing new and effective treatments and improving patient quality of life; however, many trials cannot answer their primary research questions because they fall short of their recruitment goals. This article reports the results of formative research conducted in two populations, the public and primary care physicians, to identify messages that may raise awareness and increase interest in clinical trials and be used in a national communication campaign. Results suggested that participants were primarily motivated to participate in clinical trials out of a self-interest to help themselves first. Messages illustrated that current treatments were tested via clinical trials, helped normalize trials as routine practices, and reduced concerns over trying something new first. Participants wanted messages that portray trials as state-of-the-art choices that offer some hope, show people like themselves, and are described in a clear, concise manner with actionable steps for them to take. The study revealed some differences in message salience, with healthy audiences exhibiting lower levels of interest. Our results suggest that targeted messages are needed, and that communication with primary health-care providers is an important and necessary component in raising patient awareness of the importance of clinical trials.